Cargando…

Altered sodium channel-protein associations in critical illness myopathy

BACKGROUND: During the acute phase of critical illness myopathy (CIM) there is inexcitability of skeletal muscle. In a rat model of CIM, muscle inexcitability is due to inactivation of sodium channels. A major contributor to this sodium channel inactivation is a hyperpolarized shift in the voltage d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kraner, Susan D, Novak, Kevin R, Wang, Qingbo, Peng, Junmin, Rich, Mark M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441911/ https://www.ncbi.nlm.nih.gov/pubmed/22935229 http://dx.doi.org/10.1186/2044-5040-2-17

Ejemplares similares

Critical-illness-Myopathie und -Polyneuropathie
por: Senger, D., et al.
Publicado: (2017)

SARS-CoV-2-associated critical ill myopathy or pure toxic myopathy?
por: Finsterer, Josef, et al.
Publicado: (2020)

Clinical review: Critical illness polyneuropathy and myopathy
por: Hermans, Greet, et al.
Publicado: (2008)

Mechanical Signaling in the Pathophysiology of Critical Illness Myopathy
por: Kalamgi, Rebeca C., et al.
Publicado: (2016)

Critical illness myopathy after COVID-19
por: Bagnato, Sergio, et al.
Publicado: (2020)

Critical illness polyneuropathy and myopathy: a systematic review
por: Zhou, Chunkui, et al.
Publicado: (2014)

Nutritional status of patients with critical illness myopathy and/or neuropathy after covid-19 from the viewpoint of physical rehabilitation
por: Majdič, N., et al.
Publicado: (2021)

Masseter Muscle Myofibrillar Protein Synthesis and Degradation in an Experimental Critical Illness Myopathy Model
por: Akkad, Hazem, et al.
Publicado: (2014)

The Effect of Nutritional Status in the Pathogenesis of Critical Illness Myopathy (CIM)
por: Ogilvie, Hannah, et al.
Publicado: (2014)

Critical Illness Myopathy: Diagnostic Approach and Resulting Therapeutic Implications
por: Rodriguez, Belén, et al.
Publicado: (2022)

Critical illness myopathy as a consequence of Covid-19 infection
por: Tankisi, H., et al.
Publicado: (2020)

Inactivation and Secondary Structure in the D4/S4-5 Region of the SkM1 Sodium Channel
por: Filatov, Gregory N., et al.
Publicado: (1998)

Risk factors in critical illness myopathy during the early course of critical illness: a prospective observational study
por: Weber-Carstens, Steffen, et al.
Publicado: (2010)

Is plasma calcium concentration implicated in the development of critical illness polyneuropathy and myopathy?
por: Anastasopoulos, Dimitri, et al.
Publicado: (2011)

Vitamin D serum level in subjects with critical illness polyneuropathy and myopathy
por: Intiso, Domenico, et al.
Publicado: (2020)

Critical illness myopathy and polyneuropathy in Covid-19: Is it a distinct entity?
por: Tankisi, H.
Publicado: (2021)

Critical illness myopathy and polyneuropathy - A challenge for physiotherapists in the intensive care units
por: Pattanshetty, Renu B., et al.
Publicado: (2011)

Inflammation-Induced Acute Phase Response in Skeletal Muscle and Critical Illness Myopathy
por: Langhans, Claudia, et al.
Publicado: (2014)

Intensive care unit acquired weakness in children: Critical illness polyneuropathy and myopathy
por: Kukreti, Vinay, et al.
Publicado: (2014)

Clinical, Neurophysiological and Neuroimaging Findings of Critical Illness Myopathy After COVID-19
por: Kayim Yildiz, Ozlem, et al.
Publicado: (2021)

Critical Illness Weakness, Polyneuropathy and Myopathy: Diagnosis, treatment, and long-term outcomes
por: Latronico, Nicola, et al.
Publicado: (2023)

Approach to critical illness myopathy and polyneuropathy in the older SARS-CoV-2 patients
por: McClafferty, Brendan, et al.
Publicado: (2020)

Case Report: Myopathy in Critically Ill COVID-19 Patients: A Consequence of Hyperinflammation?
por: Versace, Viviana, et al.
Publicado: (2021)

Multiple drugs: Critical illness myopathy following off-label use: case report
Publicado: (2021)

Pharmacokinetic Alterations Associated with Critical Illness
por: Morales Castro, Diana, et al.
Publicado: (2023)

Development and early diagnosis of critical illness myopathy in COVID‐19 associated acute respiratory distress syndrome
por: Rodriguez, Belén, et al.
Publicado: (2022)

RNA-sequencing reveals altered skeletal muscle contraction, E3 ligases, autophagy, apoptosis, and chaperone expression in patients with critical illness myopathy
por: Llano-Diez, Monica, et al.
Publicado: (2019)

Therapeutic Effect of Insulin in Reducing Critical Illness; Polyneuropathy and Myopathy in the Pediatric Intensive Care Unit
por: BILAN, Nemat, et al.
Publicado: (2012)

Implementing intensive insulin therapy in daily practice reduces the incidence of critical illness polyneuropathy and/or myopathy
por: Berends, N, et al.
Publicado: (2008)

Critical illness polyneuropathy, myopathy and neuronal biomarkers in COVID-19 patients: A prospective study
por: Frithiof, Robert, et al.
Publicado: (2021)

Disintegration of the NuRD Complex in Primary Human Muscle Stem Cells in Critical Illness Myopathy
por: Schneider, Joanna, et al.
Publicado: (2023)

Publisher Correction to: Critical Illness Weakness, Polyneuropathy and Myopathy: Diagnosis, treatment, and long‑term outcomes
por: Latronico, Nicola, et al.
Publicado: (2023)

Impaired Ca(2+) release contributes to muscle weakness in a rat model of critical illness myopathy
por: Llano-Diez, Monica, et al.
Publicado: (2016)

Does prolonged propofol sedation of mechanically ventilated COVID-19 patients contribute to critical illness myopathy?
por: Lönnqvist, Per-Arne, et al.
Publicado: (2020)

Urine TITIN N-fragment as a novel biomarker for critical illness myopathy: a pilot study
por: Nakano, Hidehiko, et al.
Publicado: (2020)

Recovery and long term functional outcome in people with critical illness polyneuropathy and myopathy: a scoping review
por: Intiso, Domenico, et al.
Publicado: (2022)

A prospective clinical study on the mechanisms underlying critical illness myopathy—A time‐course approach
por: Cacciani, Nicola, et al.
Publicado: (2022)

Mitochondrial Dysfunction in Intensive Care Unit-Acquired Weakness and Critical Illness Myopathy: A Narrative Review
por: Klawitter, Felix, et al.
Publicado: (2023)

Excitation-Contraction Coupling Alterations in Myopathies
por: Marty, Isabelle, et al.
Publicado: (2016)

Tolvaptan for hyponatremia with preserved sodium pool in critically ill patients
por: Umbrello, Michele, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_1gho8j78e93nk1dnriuqr4vdko